Clinical trials
Terminated Phase 2 Pancreatic Neoplasms trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
116 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2002 | 1 |
| 2003 | 1 |
| 2005 | 3 |
| 2006 | 8 |
| 2007 | 10 |
| 2008 | 7 |
| 2009 | 6 |
| 2010 | 7 |
| 2011 | 6 |
| 2012 | 7 |
| 2013 | 4 |
| 2014 | 3 |
| 2015 | 3 |
| 2016 | 3 |
| 2017 | 9 |
| 2018 | 6 |
| 2019 | 4 |
| 2020 | 7 |
| 2021 | 7 |
| 2022 | 4 |
| 2023 | 5 |
| 2025 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Terminated | 116 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Washington University School of Medicine | 5 |
| Georgetown University | 4 |
| H. Lee Moffitt Cancer Center and Research Institute | 4 |
| National Cancer Institute (NCI) | 4 |
| Herlev Hospital | 3 |
| M.D. Anderson Cancer Center | 3 |
| Albert Einstein College of Medicine | 2 |
| IRCCS San Raffaele | 2 |
| Masonic Cancer Center, University of Minnesota | 2 |
| NewLink Genetics Corporation | 2 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Pancreatic Neoplasms | 116 |
| Neoplasm Metastasis | 11 |
| Colorectal Neoplasms | 9 |
| Neoplasms | 8 |
| Ovarian Neoplasms | 8 |
| Breast Neoplasms | 7 |
| Melanoma | 7 |
| Adenocarcinoma | 5 |
| Carcinoma, Non-Small-Cell Lung | 5 |
| Sarcoma | 5 |
Trials
Showing 1 to 25 of 116. Each trial links to its page on Pharma Observatory.
16 more trials match. See them on Pharma Observatory
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.